# Workhorse Group Inc.: financial statements, quarterly

WKHS · Nasdaq · CIK 1425287 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/wkhs.md) · [Financials](/companies/wkhs/financials.md) · [Filings](/companies/wkhs/filings.md) · [Insiders](/companies/wkhs/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/wkhs/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [3.0](/filings/0001425287-24-000131.md) | [4.4 d](/filings/0001425287-25-000024.md) | [1.3](/filings/0001425287-25-000058.md) | [0.8](/filings/0001425287-25-000064.md) | [2.5](/filings/0001628280-25-051161.md) | [2.4 d](/filings/0001628280-26-022417.md) | [1.1](/filings/0001628280-26-035109.md) | [0.8](/filings/0001628280-26-056708.md) | [2.4](/filings/0001628280-25-051161.md) | [12.5 d](/filings/0001628280-26-022417.md) | [4.3](/filings/0001628280-26-035109.md) | [3.6](/filings/0001628280-26-056708.md) |
| Cost of revenue | $m | [6.6](/filings/0001425287-24-000131.md) | [18.0 d](/filings/0001425287-25-000024.md) | [7.4](/filings/0001425287-25-000058.md) | [7.3](/filings/0001425287-25-000064.md) | [6.6](/filings/0001628280-25-051161.md) | [(8.2) d](/filings/0001628280-26-022417.md) | [2.2](/filings/0001628280-26-035109.md) | [2.1](/filings/0001628280-26-056708.md) | [10.1](/filings/0001628280-25-051161.md) | [2.5 d](/filings/0001628280-26-022417.md) | [11.8](/filings/0001628280-26-035109.md) | [11.0](/filings/0001628280-26-056708.md) |
| Gross profit | $m | [(3.5)](/filings/0001425287-24-000131.md) | [(13.6) d](/filings/0001425287-25-000024.md) | [(6.1)](/filings/0001425287-25-000058.md) | [(6.5)](/filings/0001425287-25-000064.md) | [(4.1)](/filings/0001628280-25-051161.md) | [10.5 d](/filings/0001628280-26-022417.md) | [(1.1)](/filings/0001628280-26-035109.md) | [(1.4)](/filings/0001628280-26-056708.md) | [(7.7)](/filings/0001628280-25-051161.md) | [10.1 d](/filings/0001628280-26-022417.md) | [(7.5)](/filings/0001628280-26-035109.md) | [(7.5)](/filings/0001628280-26-056708.md) |
| Research and development | $m | [5.8](/filings/0001425287-24-000131.md) | [6.4 d](/filings/0001425287-25-000024.md) | [3.5](/filings/0001425287-25-000058.md) | [2.0](/filings/0001425287-25-000064.md) | [2.3](/filings/0001628280-25-051161.md) | [5.1 d](/filings/0001628280-26-022417.md) | [3.7](/filings/0001628280-26-035109.md) | [3.2](/filings/0001628280-26-056708.md) | [1.1](/filings/0001628280-25-051161.md) | [9.3 d](/filings/0001628280-26-022417.md) | [4.1](/filings/0001628280-26-035109.md) | [4.1](/filings/0001628280-26-056708.md) |
| Selling, general and administrative | $m | [11.8](/filings/0001425287-24-000131.md) | [15.1 d](/filings/0001425287-25-000024.md) | [14.1](/filings/0001425287-25-000058.md) | [12.1](/filings/0001425287-25-000064.md) | [7.7](/filings/0001628280-25-051161.md) | [(17.8) d](/filings/0001628280-26-022417.md) | [4.3](/filings/0001628280-26-035109.md) | [4.5](/filings/0001628280-26-056708.md) | [7.8](/filings/0001628280-25-051161.md) | [4.3 d](/filings/0001628280-26-022417.md) | [9.5](/filings/0001628280-26-035109.md) | [7.8](/filings/0001628280-26-056708.md) |
| Operating income | $m | [(21.1)](/filings/0001425287-24-000131.md) | [(35.2) d](/filings/0001425287-25-000024.md) | [(23.7)](/filings/0001425287-25-000058.md) | [(20.5)](/filings/0001425287-25-000064.md) | [(14.2)](/filings/0001628280-25-051161.md) | [17.1 d](/filings/0001628280-26-022417.md) | [(9.1)](/filings/0001628280-26-035109.md) | [(9.0)](/filings/0001628280-26-056708.md) | [(16.6)](/filings/0001628280-25-051161.md) | [(3.6) d](/filings/0001628280-26-022417.md) | [(21.1)](/filings/0001628280-26-035109.md) | [(19.4)](/filings/0001628280-26-056708.md) |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [0.0](/filings/0001425287-24-000131.md) | [(0.1) d](/filings/0001425287-25-000024.md) | [0.0](/filings/0001425287-25-000058.md) | [0.0](/filings/0001425287-25-000064.md) | [0.0](/filings/0001628280-25-051161.md) | [0.0 d](/filings/0001628280-26-022417.md) | [0.0](/filings/0001628280-26-035109.md) | [0.0](/filings/0001628280-26-056708.md) | [0.0](/filings/0001628280-25-051161.md) | [0.0 d](/filings/0001628280-26-022417.md) | [(0.0)](/filings/0001628280-26-035109.md) | [0.0](/filings/0001628280-26-056708.md) |
| Net income | $m | [(30.6)](/filings/0001425287-24-000131.md) | [(45.3) d](/filings/0001425287-25-000024.md) | [(29.2)](/filings/0001628280-25-051161.md) | [(26.3)](/filings/0001628280-25-051161.md) | [(25.1)](/filings/0001628280-25-051161.md) | [29.0 d](/filings/0001628280-26-022417.md) | [(12.7)](/filings/0001628280-26-056708.md) | [(12.8)](/filings/0001628280-26-056708.md) | [(7.8)](/filings/0001628280-25-051161.md) | [(20.8) d](/filings/0001628280-26-022417.md) | [(19.9)](/filings/0001628280-26-056708.md) | [(20.2)](/filings/0001628280-26-056708.md) |
| Diluted EPS | $ per share | [(2.84)](/filings/0001425287-24-000131.md) | not reported | [(24.09)](/filings/0001425287-25-000058.md) | [(17.45)](/filings/0001425287-25-000064.md) | [(19.00)](/filings/0001628280-25-051161.md) | not reported | [(1.36)](/filings/0001628280-26-035109.md) | [(1.38)](/filings/0001628280-26-056708.md) | [(0.50)](/filings/0001628280-25-051161.md) | not reported | [(1.99)](/filings/0001628280-26-035109.md) | [(1.86)](/filings/0001628280-26-056708.md) |
| Basic EPS | $ per share | [(2.84)](/filings/0001425287-24-000131.md) | not reported | [(24.09)](/filings/0001425287-25-000058.md) | [(17.45)](/filings/0001425287-25-000064.md) | [(19.00)](/filings/0001628280-25-051161.md) | not reported | [(1.36)](/filings/0001628280-26-035109.md) | [(1.38)](/filings/0001628280-26-056708.md) | [(0.50)](/filings/0001628280-25-051161.md) | not reported | [(1.99)](/filings/0001628280-26-035109.md) | [(1.86)](/filings/0001628280-26-056708.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: not reported
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [38.9](/filings/0001628280-23-038780.md) | [25.8](/filings/0001425287-25-000024.md) | [6.7](/filings/0001425287-24-000101.md) | [5.3](/filings/0001425287-24-000111.md) | [3.2](/filings/0001425287-24-000131.md) | [6.6](/filings/0001628280-26-022417.md) | [2.6](/filings/0001425287-25-000058.md) | [2.2](/filings/0001425287-25-000064.md) | [12.7](/filings/0001628280-25-051161.md) | [12.2](/filings/0001628280-26-056708.md) | [0.6](/filings/0001628280-26-035109.md) | [9.6](/filings/0001628280-26-056708.md) |
| Current assets | $m | [97.8](/filings/0001628280-23-038780.md) | [93.8](/filings/0001425287-25-000024.md) | [65.6](/filings/0001425287-24-000101.md) | [59.5](/filings/0001425287-24-000111.md) | [57.5](/filings/0001425287-24-000131.md) | [34.2](/filings/0001628280-26-022417.md) | [77.5](/filings/0001425287-25-000058.md) | [63.7](/filings/0001425287-25-000064.md) | [73.0](/filings/0001628280-25-051161.md) | [59.8](/filings/0001628280-26-056708.md) | [47.0](/filings/0001628280-26-035109.md) | [56.5](/filings/0001628280-26-056708.md) |
| Total assets | $m | [146](/filings/0001628280-23-038780.md) | [142](/filings/0001425287-25-000024.md) | [114](/filings/0001425287-24-000101.md) | [105](/filings/0001425287-24-000111.md) | [101](/filings/0001425287-24-000131.md) | [37.4](/filings/0001628280-26-022417.md) | [115](/filings/0001425287-25-000058.md) | [99.3](/filings/0001425287-25-000064.md) | [117](/filings/0001628280-25-051161.md) | [118](/filings/0001628280-26-056708.md) | [103](/filings/0001628280-26-035109.md) | [110](/filings/0001628280-26-056708.md) |
| Current liabilities | $m | [25.9](/filings/0001628280-23-038780.md) | [53.3](/filings/0001425287-25-000024.md) | [41.4](/filings/0001425287-24-000101.md) | [41.7](/filings/0001425287-24-000111.md) | [49.6](/filings/0001425287-24-000131.md) | [76.9](/filings/0001628280-26-022417.md) | [80.4](/filings/0001425287-25-000058.md) | [73.5](/filings/0001425287-25-000064.md) | [60.4](/filings/0001628280-25-051161.md) | [38.9](/filings/0001628280-26-056708.md) | [38.3](/filings/0001628280-26-035109.md) | [44.3](/filings/0001628280-26-056708.md) |
| Total liabilities | $m | [33.5](/filings/0001628280-23-038780.md) | [58.6](/filings/0001425287-25-000024.md) | [46.4](/filings/0001425287-24-000101.md) | [46.7](/filings/0001425287-24-000111.md) | [54.2](/filings/0001425287-24-000131.md) | [78.2](/filings/0001628280-26-022417.md) | [84.1](/filings/0001425287-25-000058.md) | [76.9](/filings/0001425287-25-000064.md) | [84.7](/filings/0001628280-25-051161.md) | [74.9](/filings/0001628280-26-056708.md) | [76.5](/filings/0001628280-26-035109.md) | [103](/filings/0001628280-26-056708.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [15.4](/filings/0001628280-26-056708.md) | [15.7](/filings/0001628280-26-035109.md) | [35.9](/filings/0001628280-26-056708.md) |
| Current portion of debt | $m | not reported | [76.3](/filings/0001628280-26-022417.md) | not reported | not reported | not reported | [68.4](/filings/0001628280-26-022417.md) | not reported | not reported | not reported | [0.0](/filings/0001628280-26-056708.md) | [5.0](/filings/0001628280-26-035109.md) | [18.3](/filings/0001628280-26-056708.md) |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [113](/filings/0001425287-24-000131.md) | [(55.6)](/filings/0001628280-26-022417.md) | [67.4](/filings/0001628280-25-051161.md) | [58.6](/filings/0001628280-25-051161.md) | [47.3](/filings/0001628280-25-051161.md) | [(40.8)](/filings/0001628280-26-056708.md) | [(53.4)](/filings/0001628280-26-056708.md) | [(66.1)](/filings/0001628280-26-056708.md) | [32.1](/filings/0001628280-25-051161.md) | [43.0](/filings/0001628280-26-056708.md) | [26.2](/filings/0001628280-26-056708.md) | [7.2](/filings/0001628280-26-056708.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Current portion of debt: us-gaap:DebtCurrent
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(29.7) d](/filings/0001425287-24-000131.md) | [(27.5) d](/filings/0001425287-25-000024.md) | [(18.0)](/filings/0001425287-25-000058.md) | [(12.1) d](/filings/0001425287-25-000064.md) | [(10.1) d](/filings/0001628280-25-051161.md) | [2.0 d](/filings/0001628280-26-022417.md) | [(12.5)](/filings/0001628280-26-035109.md) | [(9.2) d](/filings/0001628280-26-056708.md) | [(3.3) d](/filings/0001628280-25-051161.md) | [(10.5) d](/filings/0001628280-26-022417.md) | [(16.5)](/filings/0001628280-26-035109.md) | [(24.1) d](/filings/0001628280-26-056708.md) |
| Capital expenditure | $m | [6.1 d](/filings/0001425287-24-000131.md) | [2.2 d](/filings/0001425287-25-000024.md) | [3.0](/filings/0001425287-25-000058.md) | [0.7 d](/filings/0001425287-25-000064.md) | [0.3 d](/filings/0001628280-25-051161.md) | [0.7 d](/filings/0001628280-26-022417.md) | [0.2](/filings/0001628280-26-035109.md) | [0.1 d](/filings/0001628280-26-056708.md) | [(0.3) d](/filings/0001628280-25-051161.md) | [0.6 d](/filings/0001628280-26-022417.md) | [0.1](/filings/0001628280-26-035109.md) | [0.1 d](/filings/0001628280-26-056708.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [160](/filings/0001628280-23-038780.md) | [167](/filings/0001425287-24-000101.md) | [9.3](/filings/0001425287-24-000111.md) | [10.8](/filings/0001425287-24-000131.md) | [1.2](/filings/0001425287-25-000058.md) | [1.5](/filings/0001425287-25-000064.md) | [1.3](/filings/0001628280-25-051161.md) | [9.3](/filings/0001628280-26-035109.md) | [9.3](/filings/0001628280-26-056708.md) | [15.5](/filings/0001628280-25-051161.md) | [10.0](/filings/0001628280-26-035109.md) | [10.9](/filings/0001628280-26-056708.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 10,928,585 at 2026-08-10, from the cover of the [10-Q filed 2026-08-13](/filings/0001628280-26-056708.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:39 ET. No prices; not investment advice.